|
1
|
Argiris A, Karamouzis MV, Raben D and
Ferris RL: Head and neck cancer. Lancet. 371:1695–1709. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mascolo M, Siano M, Ilardi G, Russo D,
Merolla F, De Rosa G and Staibano S: Epigenetic disregulation in
oral cancer. Int J Mol Sci. 13:2331–2353. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Clevers H: The cancer stem cell: Premises,
promises and challenges. Nat Med. 17:313–319. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen K, Huang YH and Chen JL:
Understanding and targeting cancer stem cells: Therapeutic
implications and challenges. Acta Pharmacol Sin. 34:732–740. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Donnenberg VS and Donnenberg AD: Multiple
drug resistance in cancer revisited: The cancer stem cell
hypothesis. J Clin Pharmacol. 45:872–877. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Setoguchi T, Taga T and Kondo T: Cancer
stem cells persist in many cancer cell lines. Cell Cycle.
3:414–415. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hadnagy A, Gaboury L, Beaulieu R and
Balicki D: SP analysis may be used to identify cancer stem cell
populations. Exp Cell Res. 312:3701–3710. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kondo T, Setoguchi T and Taga T:
Persistence of a small subpopulation of cancer stem-like cells in
the C6 glioma cell line. Proc Natl Acad Sci USA. 101:781–786. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang P, Zhang Y, Mao L, Zhang Z and Chen
W: Side population in oral squamous cell carcinoma possesses tumor
stem cell phenotypes. Cancer Lett. 277:227–234. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu Y, Cui P, Chen J and Li W: Isolation
and phenotypic characterization of side population cells in oral
squamous cell carcinoma. Mol Med Rep. 11:3642–3646. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yu CC, Hu FW, Yu CH and Chou MY: Targeting
CD133 in the enhancement of chemosensitivity in oral squamous cell
carcinoma-derived side population cancer stem cells. Head Neck. 38
Suppl 1:E231–E238. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chiou SH, Yu CC, Huang CY, Lin SC, Liu CJ,
Tsai TH, Chou SH, Chien CS, Ku HH and Lo JF: Positive correlations
of Oct-4 and Nanog in oral cancer stem-like cells and high-grade
oral squamous cell carcinoma. Clin Cancer Res. 14:4085–4095. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hayashi S, Tanaka J, Okada S, Isobe T,
Yamamoto G, Yasuhara R, Irie T, Akiyama C, Kohno Y, Tachikawa T and
Mishima K: Lin28a is a putative factor in regulating cancer stem
cell-like properties in side population cells of oral squamous cell
carcinoma. Exp Cell Res. 319:1220–1228. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bourguignon LY, Peyrollier K, Xia W and
Gilad E: Hyaluronan-CD44 interaction activates stem cell marker
Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated
multidrug efflux in breast and ovarian tumor cells. J Biol Chem.
283:17635–17651. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zöller M: CD44: Can a cancer-initiating
cell profit from an abundantly expressed molecule? Nat Rev Cancer.
11:254–267. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang Q, Shi S, Yen Y, Brown J, Ta JQ and
Le AD: A subpopulation of CD133(+) cancer stem-like cells
characterized in human oral squamous cell carcinoma confer
resistance to chemotherapy. Cancer Lett. 289:151–160. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Resetkova E, Reis-Filho JS, Jain RK, Mehta
R, Thorat MA, Nakshatri H and Badve S: Prognostic impact of ALDH1
in breast cancer: A story of stem cells and tumor microenvironment.
Breast Cancer Res Treat. 123:97–108. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ota N, Ohno J, Seno K, Taniguchi K and
Ozeki S: In vitro and in vivo expression of aldehyde dehydrogenase
1 in oral squamous cell carcinoma. Int J Oncol. 44:435–442. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ginestier C, Hur MH, Charafe-Jauffret E,
Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG,
Liu S, et al: ALDH1 is a marker of normal and malignant human
mammary stem cells and a predictor of poor clinical outcome. Cell
Stem Cell. 1:555–567. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Huang EH, Hynes MJ, Zhang T, Ginestier C,
Dontu G, Appelman H, Fields JZ, Wicha MS and Boman BM: Aldehyde
dehydrogenase 1 is a marker for normal and malignant human colonic
stem cells (SC) and tracks SC overpopulation during colon
tumorigenesis. Cancer Res. 69:3382–3389. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Silva IA, Bai S, McLean K, Yang K,
Griffith K, Thomas D, Ginestier C, Johnston C, Kueck A, Reynolds
RK, et al: Aldehyde dehydrogenase in combination with CD133 defines
angiogenic ovarian cancer stem cells that portend poor patient
survival. Cancer Res. 71:3991–4001. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen YC, Chen YW, Hsu HS, Tseng LM, Huang
PI, Lu KH, Chen DT, Tai LK, Yung MC, Chang SC, et al: Aldehyde
dehydrogenase 1 is a putative marker for cancer stem cells in head
and neck squamous cancer. Biochem Biophys Res Commun. 385:307–313.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ma S, Chan KW, Lee TK, Tang KH, Wo JY,
Zheng BJ and Guan XY: Aldehyde dehydrogenase discriminates the
CD133 liver cancer stem cell populations. Mol Cancer Res.
6:1146–1153. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu W, Wu L, Shen XM, Shi LJ, Zhang CP, Xu
LQ and Zhou ZT: Expression patterns of cancer stem cell markers
ALDH1 and CD133 correlate with a high risk of malignant
transformation of oral leukoplakia. Int J Cancer. 132:868–874.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wiklund ED, Gao S, Hulf T, Sibbritt T,
Nair S, Costea DE, Villadsen SB, Bakholdt V, Bramsen JB, Sørensen
JA, et al: MicroRNA alterations and associated aberrant DNA
methylation patterns across multiple sample types in oral squamous
cell carcinoma. PLoS One. 6:e278402011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Scapoli L, Palmieri A, Lo Muzio L,
Pezzetti F, Rubini C, Girardi A, Farinella F, Mazzotta M and
Carinci F: MicroRNA expression profiling of oral carcinoma
identifies new markers of tumor progression. Int J Immunopathol
Pharmacol. 23:1229–1234. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang X, Su Y, Zhang M and Sun Z: Opposite
effects of arsenic trioxide on the Nrf2 pathway in oral squamous
cell carcinoma in vitro and in vivo. Cancer Lett. 318:93–98. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang W, Li X, Wang F and Sun XY: Effect of
TET1 regulating MGMT on chemotherapy resistance of oral squamous
cell carcinoma stem cells. J Cell Biochem. 119:723–735. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Scharenberg CW, Harkey MA and Torok-Storb
B: The ABCG2 transporter is an efficient Hoechst 33342 efflux pump
and is preferentially expressed by immature human hematopoietic
progenitors. Blood. 99:507–512. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pandey S, Walpole C, Cabot PJ, Shaw PN,
Batra J and Hewavitharana AK: Selective anti-proliferative
activities of Carica papaya leaf juice extracts against prostate
cancer. Biomed Pharmacother. 89:515–523. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang X, Liu Q, Hou B, Zhang W, Yan M, Jia
H, Li H, Yan D, Zheng F, Ding W, et al: Concomitant targeting of
multiple key transcription factors effectively disrupts cancer stem
cells enriched in side population of human pancreatic cancer cells.
PLoS One. 8:e739422013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Park T, Yi SG, Kang SH, Lee S, Lee YS and
Simon R: Evaluation of normalization methods for microarray data.
BMC Bioinformatics. 4:332003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Saeed AI, Sharov V, White J, Li J, Liang
W, Bhagabati N, Braisted J, Klapa M, Currier T, Thiagarajan M, et
al: TM4: A free, open-source system for microarray data management
and analysis. Biotechniques. 34:374–378. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Eisen MB, Spellman PT, Brown PO and
Botstein D: Cluster analysis and display of genome-wide expression
patterns. Proc Natl Acad Sci USA. 95:14863–14868. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ho MM, Ng AV, Lam S and Hung JY: Side
population in human lung cancer cell lines and tumors is enriched
with stem-like cancer cells. Cancer Res. 67:4827–4833. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tirino V, Desiderio V, Paino F, De Rosa A,
Papaccio F, La Noce M, Laino L, De Francesco F and Papaccio G:
Cancer stem cells in solid tumors: An overview and new approaches
for their isolation and characterization. FASEB J. 27:13–24. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bonnet D and Dick JE: Human acute myeloid
leukemia is organized as a hierarchy that originates from a
primitive hematopoietic cell. Nat Med. 3:730–737. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Mackenzie IC: Growth of malignant oral
epithelial stem cells after seeding into organotypical cultures of
normal mucosa. J Oral Pathol Med. 33:71–78. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Locke M, Heywood M, Fawell S and Mackenzie
IC: Retention of intrinsic stem cell hierarchies in
carcinoma-derived cell lines. Cancer Res. 65:8944–8950. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Narayan S, Bryant G, Shah S, Berrozpe G
and Ptashne M: OCT4 and SOX2 work as transcriptional activators in
reprogramming human fibroblasts. Cell Rep. 20:1585–1596. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Marucci L: Nanog dynamics in mouse
embryonic stem cells: Results from systems biology approaches. Stem
Cells Int. 2017:71604192017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Polyak K and Weinberg RA: Transitions
between epithelial and mesenchymal states: Acquisition of malignant
and stem cell traits. Nat Rev Cancer. 9:265–273. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Shenouda SK and Alahari SK: MicroRNA
function in cancer: Oncogene or a tumor suppressor? Cancer
Metastasis Rev. 28:369–378. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Lo HW and Hung MC: Nuclear EGFR signalling
network in cancers: Linking EGFR pathway to cell cycle progression,
nitric oxide pathway and patient survival. Br J Cancer. 96
Suppl:R16–R20. 2007.PubMed/NCBI
|
|
47
|
Ribeiro FA, Noguti J, Oshima CT and
Ribeiro DA: Effective targeting of the epidermal growth factor
receptor (EGFR) for treating oral cancer: A promising approach.
Anticancer Res. 34:1547–1552. 2014.PubMed/NCBI
|
|
48
|
Liu X, Liang Z, Gao K, Li H, Zhao G, Wang
S and Fang J: MicroRNA-128 inhibits EMT of human osteosarcoma cells
by directly targeting integrin α2. Tumor Biol. 6:7951–7957. 2016.
View Article : Google Scholar
|
|
49
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: At the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Chin SP, Marthick JR, West AC, Short AK,
Chuckowree J, Polanowski AM, Thomson RJ, Holloway AF and Dickinson
JL: Regulation of the ITGA2 gene by epigenetic mechanisms in
prostate cancer. Prostate. 75:723–734. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ding W, Fan XL, Xu X, Huang JZ, Xu SH,
Geng Q, Li R, Chen D and Yan GR: Epigenetic silencing of ITGA2 by
MiR-373 promotes cell migration in breast cancer. PLoS One.
10:e01351282015. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Parajuli H, Sapkota D, Suleiman S, Cormack
EM, Johannessen AC, Gullberg D and Costea DE: 28 Expression of
integrin α-11 by carcinoma associated fibroblasts modulates oral
squamous cell carcinoma behavior. Oral Oncol. 51:e362015.
View Article : Google Scholar
|
